Bandila, Ahil M.
HRN: 23-23-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2023
CEFUROXIME 750MG (VIAL)
08/20/2023
08/27/2023
IV
256mg
TID
AGE W/ Mod. Dehydration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes